AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 128 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $442,000 | -24.8% | 58,772 | +23.8% | 0.05% | 0.0% |
Q1 2022 | $588,000 | -67.5% | 47,462 | -66.0% | 0.05% | -66.0% |
Q2 2021 | $1,808,000 | +12.2% | 139,499 | +25.7% | 0.15% | -50.8% |
Q1 2020 | $1,611,000 | -28.4% | 111,000 | 0.0% | 0.30% | +56.4% |
Q4 2019 | $2,249,000 | +4064.8% | 111,000 | +825.0% | 0.20% | +4775.0% |
Q4 2017 | $54,000 | -76.6% | 12,000 | -67.5% | 0.00% | -73.3% |
Q3 2017 | $231,000 | -45.4% | 36,900 | -81.7% | 0.02% | -62.5% |
Q4 2016 | $423,000 | – | 201,522 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 230,000 | $993,600 | 1.92% |
AlphaCentric Advisors LLC | 352,500 | $1,522,800 | 1.50% |
NEA Management Company, LLC | 3,969,834 | $17,149,683 | 0.96% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 573,530 | $2,477,650 | 0.76% |
ARMISTICE CAPITAL, LLC | 5,000,000 | $21,600,000 | 0.38% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 93,658 | $404,603 | 0.27% |
Artal Group S.A. | 1,000,000 | $4,320 | 0.24% |
Virtus ETF Advisers LLC | 64,786 | $279,876 | 0.15% |
TANG CAPITAL MANAGEMENT LLC | 200,000 | $864,000 | 0.13% |
HighMark Wealth Management LLC | 37,499 | $161,996 | 0.12% |